The government panel backs continued home drug delivery, prioritizing medicine access for vulnerable patients while calling for tighter online sales enforcement.
Ayurveda seeks to bridge tradition and modern medicine through preventive healthcare, evidence-based research, innovation, and integrative care.
India’s peptide API race heats up as HRV Pharma commits Rs 150 crore to expand synthetic peptide and high-potency oncology API capacity.
Roche Pharma India announced the winners of the third edition of the Leading Engagements to Advance Patient Care (LEAP) program.
Chronic care and GLP-1 therapeutics are reshaping the Indian Pharmaceutical Market as long-term therapies drive growth, demand, and investment.
Novartis India has approved a Rs 1,250 crore deal to acquire Pfizer's Minipress and Minipress trademarks in India. The deal also includes certain related intellectual property rights. The company’s board approved the transaction...
Nadda pushes advanced diagnostics at Safdarjung Hospital, adding specialized facilities to strengthen affordable patient care and diagnostic capacity.
India could face 16.9 million dementia cases by 2036, making a stronger dementia care ecosystem an urgent priority now.
Manipur Chief Minister Yumnam Khemchand Singh meets Union Health and Family Welfare Minister JP Nadda in New Delhi. During the discussion, Nadda agrees to upgrade the Regional Institute of Medical Sciences in Imphal to AIIMS
The push to lower drug prices in America has gained momentum as Sun Pharma joins eight pharmaceutical companies in a new US pricing deal.